Istanbul University Institute of Oncology
Istanbul, Capa, 34190, Turkey (Türkiye)
NCT Number: NCT00867295
This randomized trial is determining the role of antibiotic prophylaxis in the prevention of the infectious complications in patients carrying out totally implantable venous access device.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Phase 3
Istanbul, Capa, 34190, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
cefazolin Sodium 1g i.v. before operation
placebo
Time frame: 30 days
Istanbul University
Other
A Randomized, Double-blind, Placebo-controlled Trial to Determine Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device.
Acronym: TIVAD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05507736
Diarrhea, Neoplasms
Esplugues de Llobregat, Barcelona, Spain
View Trial DetailsNCT06209385
Solid Tumor
Nanchang, Jiangxi, China
View Trial DetailsNCT05991349
Solid Tumor
Camperdown, New South Wales, Australia
View Trial DetailsNCT05708950
Adnexal Diseases, Breast Cancer
Santa Monica, California, United States
View Trial Details